Inspired by his son's illness, Ron Davis and colleagues have discovered a diagnostic test for chronic fatigue syndrome, a notoriously elusive disease.
By scouting for a particular immune cell in the blood, scientists can tell which patients with a lung-scarring disease are at higher risk for death.
Study finds that starting colorectal cancer screening at age 45 would avert deaths, but testing more older people would be more beneficial.
A push to personalize medicine can backfire when it comes to screening for colorectal cancer, says a Stanford gastroenterologist.
Doctors are trying to solve the mysteries surrounding the health of famous artists such as Leonardo da Vinci by examining their art.
Scientists have modified immune cells, imbuing them with the ability to not only detect, but reveal, the presence of a tumor.
A pattern of inflammatory activity in circulating blood cells just two days after a stroke predicts the loss of substantial mental acuity a full year later.
Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.
A new blood test measures the DNA fragments of lung transplant donors in the blood of recipients, in hopes of preventing organ rejection and saving lives.
A Stanford surgeon, educator and inventor has worked to advance the science of touch.
Stanford researchers led by Gill Bejerano have developed an algorithm that can rapidly inform diagnoses using clinical records.
Scientists create algorithms that read X-rays and MRIs in an effort to enhance doctor's diagnoses of certain disease and injury.
A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases.
PHIND scientists discuss how to stop disease in its track, aiming for earlier diagnostics and more precise medical treatments.
The ratio between a certain types of immune cells is able to predict whether latent TB will shift into an active infection, new research has found.
Monitoring changes in the levels of circulating bits of tumor DNA may help some lymphoma patients avoid unnecessary chemotherapy, Stanford researchers find.